Mark Pruzanski

Mark Pruzanski

Voorzitter bij INVENTIVA

Vermogen: 32 605 $ op 31-10-2026

58 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Mark E.
Pruzanski
was the founder of Apple Tree Venture Management Llc, founded in 1999, serving as Venture Partner from 1999 to 2002.
Dr. Pruzanski was the founder of Intercept Pharmaceuticals, Inc., founded in 2002, serving as Director from 2021 to 2023.
Dr. Pruzanski is the founder of Kirax Corp., founded in 2005.
Current jobs include Chief Executive Officer at Alentis Therapeutics AG starting in 2025, Chairman at Inventiva SA starting in 2024, Director at Biotechnology Innovation Organization, Director at Foundation for the Defense of Democracies, Director at eGenesis, Inc., Independent Director at Equillium, Inc. since 2018, and Director at Intercept Pharma Europe Ltd. since 2015.
Former jobs include Chief Executive Officer at MedicinePlanet, Inc., President & Chief Executive Officer at gIcare Pharma, Inc., Chief Executive Officer at Versanis Bio, Inc. from 2021 to 2023, Director at Evelo Biosciences, Inc., and Entrepreneur-in-Residence at Oak Investment Partners.
Education includes graduate studies at Paul H.
Nitze School of Advanced International Studies (IT), undergraduate degree from McGill University in 1989, doctorate from McMaster University in 1998, and graduate degree from Johns Hopkins University School of Advanced International in 1991.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
28-05-2026 23.799 ( 0,04% ) 32 605 $ 31-10-2026
01-03-2026 0 ( -.--% ) - $ 31-10-2026

Actieve functies van Mark Pruzanski

BedrijvenFunctieBegin
INVENTIVA Voorzitter 13-12-2024
EQUILLIUM, INC. Directeur/Bestuurslid 01-09-2018
Algemeen Directeur 15-10-2025
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid 19-08-2015
Directeur/Bestuurslid -

Eerdere bekende functies van Mark Pruzanski

BedrijvenFunctieEinde
INTERCEPT PHARMACEUTICALS, INC. Algemeen Directeur 01-01-2021
Algemeen Directeur 01-09-2023
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ervaring van Mark Pruzanski in detail bekijken

Opleiding van Mark Pruzanski

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

69

Eerstegraads connecties

19

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit19

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Finance

Commercial Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Mark Pruzanski